EA201591826A1 - Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения - Google Patents

Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения

Info

Publication number
EA201591826A1
EA201591826A1 EA201591826A EA201591826A EA201591826A1 EA 201591826 A1 EA201591826 A1 EA 201591826A1 EA 201591826 A EA201591826 A EA 201591826A EA 201591826 A EA201591826 A EA 201591826A EA 201591826 A1 EA201591826 A1 EA 201591826A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
particles
retinoid
local application
fine dry
Prior art date
Application number
EA201591826A
Other languages
English (en)
Inventor
Синь Чень
Родика-Татьяна Канелид
Захра Манзури
Original Assignee
Лаборатори Скин Кеар, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201591826(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лаборатори Скин Кеар, Инк. filed Critical Лаборатори Скин Кеар, Инк.
Publication of EA201591826A1 publication Critical patent/EA201591826A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Предусмотрены тонкодисперсные сухие ретиноидные композиции, подходящие для применения в составах для местного применения, а также способы их получения. В сухих дисперсных ретиноидных композициях ретиноидное активное средство связано с частицами, например, посредством удержания частиц в порах, и/или образования ионной связи, и/или образования нековалентной связи с поверхностью частиц и/или слабо связано с частицами. Также предусмотрены составы для местного применения, которые включают в себя сухие дисперсные ретиноидные композиции согласно настоящему изобретению, и способы их применения.
EA201591826A 2013-03-15 2014-03-14 Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения EA201591826A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798758P 2013-03-15 2013-03-15
US201461938080P 2014-02-10 2014-02-10
PCT/US2014/029673 WO2014145034A1 (en) 2013-03-15 2014-03-14 Fine dry particulate retinoid active agent compositions and topical formulations including the same

Publications (1)

Publication Number Publication Date
EA201591826A1 true EA201591826A1 (ru) 2016-01-29

Family

ID=51528082

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591826A EA201591826A1 (ru) 2013-03-15 2014-03-14 Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения

Country Status (15)

Country Link
US (5) US20140271879A1 (ru)
EP (1) EP2968157B1 (ru)
JP (1) JP2016514694A (ru)
KR (1) KR20150131285A (ru)
CN (2) CN112263549A (ru)
AU (1) AU2014233420A1 (ru)
BR (1) BR112015023117A2 (ru)
CA (1) CA2906838A1 (ru)
CL (1) CL2015002688A1 (ru)
EA (1) EA201591826A1 (ru)
MX (1) MX366277B (ru)
MY (1) MY183106A (ru)
NZ (1) NZ713342A (ru)
SG (1) SG11201507667SA (ru)
WO (1) WO2014145034A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2480210A4 (en) * 2008-09-23 2016-07-13 Lab Skin Care Inc ACTUATED UNIFORMS, RIGID, SPHERICAL NANOPOROUS CALCIUMOPHOSPHATE PARTICLES AND METHOD FOR THEIR USE AND MANUFACTURE
NZ713342A (en) * 2013-03-15 2020-12-18 Laboratory Skin Care Inc Fine dry particulate retinoid active agent compositions and topical formulations including the same
WO2016073529A1 (en) * 2014-11-03 2016-05-12 Stella & Dot Llc Skincare formulations and regimens
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CN113181073B (zh) * 2021-04-30 2022-12-23 广州市科能化妆品科研有限公司 一种复合维生素乳液、祛皱精华霜及其制备方法
WO2024045049A1 (en) * 2022-08-31 2024-03-07 L'oreal Composition for caring for keratin materials and mask containing the same
CN115820338A (zh) * 2023-02-22 2023-03-21 中国科学院昆明植物研究所 一种脱臭青刺果油的制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
FR2717686B1 (fr) * 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Composition dermo-cosmétologique et procédé de préparation.
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
FR2774907B1 (fr) * 1998-02-19 2000-05-12 Luc Dewandre Nouvelle formulation topique a base de retinaldehyde
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
EP1674093A4 (en) * 2003-10-15 2009-12-09 Nanoegg Res Lab Inc METHOD OF CHECKING THE PARTICLE SIZE OF RETINOLIC ACID NANOTEILS WITH A COATING OF POLYVALENT INORGANIC METAL SALT AND NANOTEHTES OBTAINED BY THE CONTROL PROCEDURE
JPWO2009096481A1 (ja) * 2008-01-30 2011-05-26 Ｔｂｃグループ株式会社 皮膚外用組成物および美白化粧料
EP2480210A4 (en) * 2008-09-23 2016-07-13 Lab Skin Care Inc ACTUATED UNIFORMS, RIGID, SPHERICAL NANOPOROUS CALCIUMOPHOSPHATE PARTICLES AND METHOD FOR THEIR USE AND MANUFACTURE
WO2010050980A1 (en) 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
ES2942923T3 (es) * 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN102905675B (zh) * 2009-11-10 2018-11-16 护肤品实验室有限公司 包含均匀、硬质、球形、纳米多孔磷酸钙颗粒的防晒剂组合物及其制备和使用方法
NZ713342A (en) * 2013-03-15 2020-12-18 Laboratory Skin Care Inc Fine dry particulate retinoid active agent compositions and topical formulations including the same
US11318077B2 (en) * 2017-09-29 2022-05-03 Rodan & Fields, Llc Retinaldehyde containing compositions and methods of use

Also Published As

Publication number Publication date
CN112263549A (zh) 2021-01-26
US20140271879A1 (en) 2014-09-18
EP2968157A4 (en) 2016-12-14
MY183106A (en) 2021-02-15
CN105358135A (zh) 2016-02-24
EP2968157A1 (en) 2016-01-20
US20180028469A1 (en) 2018-02-01
EP2968157B1 (en) 2023-11-08
MX366277B (es) 2019-07-04
US20200222336A1 (en) 2020-07-16
SG11201507667SA (en) 2015-10-29
CA2906838A1 (en) 2014-09-18
NZ713342A (en) 2020-12-18
MX2015013254A (es) 2016-04-15
US20210259991A1 (en) 2021-08-26
AU2014233420A8 (en) 2015-11-26
US20160317469A1 (en) 2016-11-03
AU2014233420A1 (en) 2015-11-12
CL2015002688A1 (es) 2016-04-08
BR112015023117A2 (pt) 2017-07-18
WO2014145034A1 (en) 2014-09-18
KR20150131285A (ko) 2015-11-24
JP2016514694A (ja) 2016-05-23

Similar Documents

Publication Publication Date Title
EA201591826A1 (ru) Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения
EA201690667A1 (ru) Композиции, содержащие антитело к pdl1
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201491486A1 (ru) Производные пиперидинопиримидина для лечения вирусных инфекций
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
EA201590931A1 (ru) Гетероциклические замещенные производные 2-амино-хиназолина для лечения вирусных инфекций
EA202090547A3 (ru) Макроциклические деаза-оксипурины для лечения вирусных инфекций
EA201590731A1 (ru) Антитела к гемагглютинину и способы применения
EA201592213A1 (ru) Антитела антирецептор трансферрина и способы их использования
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201690930A1 (ru) Композиции и способы модуляции фарнезоидных х-рецепторов
MY192489A (en) Selectively substituted quinoline compounds
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
BR112014020826A2 (pt) moduladores e métodos de uso
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
BR112015021521A2 (pt) anticorpos anti-crth2 e métodos para seu uso
BR112015012547A2 (pt) composições de prostaciclina e métodos de sua utilização
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
EA201590887A1 (ru) Композиция
EA201390660A1 (ru) Модифицированные никотиновые соединения и связанные способы
EA201690992A1 (ru) Антитела, специфичные к fcrn
EA201790461A1 (ru) Композиции внеклеточного матрикса
EA201591996A1 (ru) Способы и композиции для заживления раны